Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGIFNα1b Phase I in Healthy Chinese Adults
NCT05639803Phase 1Completed
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of peginterferon alfa-1b in herpes zoster (HZ) (6 arms), sponsored by Shanghai Institute of Biological Products. Primary endpoints: Number of adverse events, λz and 5 more. Started Jul 2020; status: completed.
02
Drugs
peginterferon alfa-1b
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05639803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05639803.